Clinical trial
Feasibility, Acceptability, and Preliminary Effects of e-Perinatal Butterfly, an Embedded Digital Intervention for Parents Experiencing Perinatal Loss
NCT07898176 is registered in ClinicalTrials.gov with University of Seville as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, 14-day trial. Card required. Your first charge is when the trial ends. See pricing
Registry record
As filed in ClinicalTrials.gov.
- Title
- Feasibility, Acceptability, and Preliminary Effects of e-Perinatal Butterfly, an Embedded Digital Intervention for Parents Experiencing Perinatal Loss
- Lead sponsor
- University of Seville
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- January 12, 2027
- Completion date
- June 30, 2028
- Enrollment
- 60 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
anxiety symptoms, depressive symptoms, perinatal grief, perinatal loss
Arms
As registered; 2 arms.
-
Intervention group
-
Control group
Primary endpoints
Registered primary outcome measures; 3 primary.
-
Feasibility of the intervention
Calculation of participation rate, recruitment rate, and retention rate (follow-up rate) at all assessment points. Assessment method: Registration and follow-up records.
-
Early acceptability
Number of eligible women and partners who agree to participate. Assessment method: Login to e-Perinatal Butterfly.
-
Final acceptability
Evaluation of how appropriate, satisfactory, and feasible the intervention is after its implementation. Assessment method: Surveys and semi-structured interviews based on the Normalization Process Theory.
Lead sponsor's other trials
University of Seville, most recent start first.
+124 more trials
Similar trials
Same condition (Perinatal Death) and phase, most recent start first.
+56 more trials See the condition page